Simon Lacey

Simon Lacey is an experienced T cell immunologist who currently serves as the Vice President of Immunology at Asklepios BioPharmaceutical, Inc. (AskBio), a position he has held since January 2022.1 With over a decade of experience in directing correlative studies, Lacey brings extensive expertise to his role at AskBio, a biotechnology company focused on gene therapy and pharmaceuticals.2

Career Background

Prior to joining AskBio, Lacey had a distinguished career in academia and research:

• University of Pennsylvania: He spent over 8 years at the Perelman School of Medicine, where he served as the Director of the Translational and Correlative Studies Laboratory from October 2013 to January 2022.1

• City of Hope: For 14 years, Lacey worked at the City of Hope Cancer Center, where he held the position of Associate Research Professor and Director of the Clinical Immunobiology Correlative Studies Laboratory.1

• Duke University Medical Center: He worked as a Research Fellow, focusing on HIV research from 1995 to 1998.1

• Wellcome Research Laboratories: Lacey began his professional career here, working on HIV antiviral drug resistance from 1990 to 1993.1

Education

Lacey's educational background includes:

• A Ph.D. in Virology from the National Institute for Medical Research, Mill Hill, London (1987-1990).1
• A B.Sc. in Biochemistry from Imperial College London (1983-1987).1

Expertise

Simon Lacey's areas of expertise include:

• Tumor Immunology
• HIV Immunology
• BK Virus Adoptive Immunotherapy
• T-cell Immunology
• Cancer Immunotherapy
• CAR T Cells3

His work has contributed to advancements in these fields, with articles on topics such as improving CAR19 through Tet2 disruption.1

Simon Lacey's extensive experience in immunology and his leadership roles in both academic and industry settings make him a valuable asset in his current position at AskBio, where he continues to contribute to the development of innovative biopharmaceutical solutions.